Usefulness of positron emission tomography imaging in the management of lung cancer

Current Opinion in Pulmonary Medicine

Volumn 5, Issue 4, 1999, Pages 201-207

  Sarinas, Priscilla S A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COST BENEFIT ANALYSIS; DIFFERENTIAL DIAGNOSIS; ECONOMICS; FEMALE; HUMAN; LUNG DISEASE; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METASTASIS; METHODOLOGY; PATHOLOGY; REVIEW; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

CARCINOMA, NON-SMALL-CELL LUNG; COST-BENEFIT ANALYSIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033161379     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199907000-00004     Document Type: Article

References (6)

1. Gucalp R, Dutcher JP, Wiemik PH: Overview by an oncologist: what are the imaging needs of the oncologist and oncological surgeon? Semin Nucl Med 1997, 27:3-9.
2. Conti PS, Lilien DL, Hawley K, Keppler J, Grafton ST, Bading JR: PET and [18F]-FDG in oncology: a clinical update. Nucl Med Biol 1996, 23:717-735.
3. Hoh CK, Schiepers C, Seltzer MA, Gambhier SS, Silverman DH, Czemin J, et al.: PET in oncology: will it replace the other modalities? Semin Nucl Med 1997, 27:94-106.
4. Fischman AJ, Alpert NM: FDG-PET in oncology: there's more to it than looking at pictures [editorial; comment]. J Nucl Med 1993,34:6-11.
5. Erasmus JJ, McAdams HP, Patz EF Jr, Goodman PC, Coleman RE: Thoracic FDG PET: state of the art. Radiographies 1998,18:5-20. This is a good review for the clinical uses of PET.
6. Gupta N, Gill H, Graeber G, Bishop H, Hurst J, Stephens T: Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions. Chest 1998,114:1105-1111.